Product Information

OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Lifestar Pharma LLC, priced at $0.1635 per EA under NDC 70756081230. Its NADAC has been published 324 times since Sep 9, 2020.

FDA first approved this application on Sep 17, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB

Olmesartan Medoxomil and Hydrochlorothiazide
$0.1635per EA

Strength

12.5; 20 mg/1; mg/1

NDC

70756081230

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208847

FDA Approved

9/17/2019

TE Code

AB

On Market Since

10/1/2020

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 324 times since Sep 9, 2020, and over the history we have for it it has declined 70.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1635 per EA
All-time high$0.6620 (Oct 14, 2020)
All-time low$0.1502 (Nov 20, 2024)
52-week high$0.1842
52-week low$0.1635
Median price$0.2028
Average price$0.2212
Largest weekly change-40.2% (Nov 18, 2020)
Weeks tracked324
Tracking sinceSep 9, 2020

Price History

1W

-0.3%

1M

-0.3%

3M

-9.4%

6M

-6.6%

1Y

-2.9%

3Y

-17.9%

5Y

-35.0%

All

-70.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Lifestar Pharma LLC, is $0.1635 per EA (NDC 70756081230), effective Nov 18, 2026.

How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 70.6%. It has been tracked across 324 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Since Sep 9, 2020, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1502 (Nov 20, 2024) to a high of $0.6620 (Oct 14, 2020), with a median of $0.2028 per EA.

Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 70756081230) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.